Advancements in development of novel class of HIV protease inhibitors
{{output}}
Background: Protease (PR) inhibitors (PIs) are widely regarded as the most significant agents in the treatment of human immunodeficiency virus (HIV) and have been instrumental in the success of highly active antiretroviral therap... ...
